of multiple tumor types and become a validated and attractive target for cancer therapy. In this work, a series of 1-phenyl-1H-indole derivatives has been designed and synthesized. The preliminary biological studies (binding assay for Bcl-2 proteins and MTT assay) suggested that some active compounds showed potent inhibitory activities on Bcl-2/Mcl-1 without binding on Bcl-XL. Furthermore, Compound 9c
Bc
L-2蛋白,例如B细胞淋巴瘤(Bc
L-2)蛋白,髓样细胞白血病序列1(Mcl-1)蛋白,已牵涉多种肿瘤类型的进展和存活,并成为经验证且有吸引力的靶标癌症治疗。在这项工作中,已经设计并合成了一系列的1-
苯基-1 H-
吲哚衍
生物。初步的
生物学研究(Bc
L-2蛋白的结合测定和M
TT测定)表明,某些活性化合物对Bc
L-2 / Mcl-1表现出有效的抑制活性,而对Bcl-XL不起约束作用。此外,化合物9c和9h显示出更好的抗-增殖活性高于W
L-276。